banner
siRNA/Cisplatin-liposome-codelivery hydrogels
Inquiry

Cat. No.: X26-04-ZQ2517

siRNA/Cisplatin-liposome-codelivery hydrogels

Synonym: siRNA-Cisplatin co-delivery; siRNA-CDDP liposome gel; siRNA/CDDP@Gel

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
siRNA/cisplatin-liposome-codelivery hydrogels are sophisticated multi-barrier delivery systems. The composition features small interfering RNA (siRNA) and cisplatin co-loaded into liposomes, which are then integrated into a hydrogel matrix. The structure is designed to investigate the coordinated release of genetic and chemical agents in experimental material research.
Source
Custom synthesis
Form
Solid
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Applications
This product can be used for the study of co-delivery mechanisms, the development of liposome-hydrogel hybrids for research, and research into molecular stabilization.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.
0